Pharmaceuticals, Biotechnology and Life Sciences
Initial data from Phase 1 combination with capecitabine in advanced ovarian cancer are expected in mid-2023 Dose for the Phase…
$71.0 million cash balance at the end of 2022 expected to provide cash runway into 2025 Acquired Bioniz Therapeutics, including…
Pragma Bio developed a first-of-its-kind-map of chemicals designed by nature, housed in humans, and linked to immune-related health outcomes SOUTH…
BUDAPEST, Hungary–(BUSINESS WIRE)–Two leading pathology and diagnostics companies, 3DHISTECH of Hungary and Epredia, a member of PHC Group (headquartered in…
IRVINE, Calif.–(BUSINESS WIRE)–IPS-Integrated Project Services, LLC, a leading provider of engineering, procurement, construction management, and validation (EPCMV) services, welcomes Mihir…
NEW YORK–(BUSINESS WIRE)–#clinicalresearch—Medidata, a Dassault Systèmes company, launched Rave EDC Certified Study Builder certification, a new offering in its global…
Phase III study ARASTEP initiated in hormone-sensitive prostate cancer, in patients with high-risk biochemical recurrence (BCR) who have no evidence…
Headlands Research Detroit focuses on clinical trials of priority diseases and conditions for the local population SAN FRANCISCO–(BUSINESS WIRE)–#alzresearch—Headlands Research,…
DUBLIN–(BUSINESS WIRE)–The “Tetraspecific Antibodies Clinical Trials, Proprietary Technologies, Companies & Market Trends Insight 2023” report has been added to ResearchAndMarkets.com’s…
SAN DIEGO–(BUSINESS WIRE)–Autobahn Therapeutics, a biotechnology company focused on restoring hope for people affected by CNS disorders, today announced that…